Viewing Study NCT07013851


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-29 @ 9:39 PM
Study NCT ID: NCT07013851
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
Sponsor: Grupo Español de Investigación en Cáncer de Ovario
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module